Free Cancer Screening Guidelines
National Foundation for Cancer Research Welcomes Three New Board Members
National Foundation for Cancer Research Appoints Brain Cancer Charity CEO, Renowned Cancer Researcher, and Dermatology Professor as Newest Board Members FOR IMMEDIATE RELEASE January 31, 2022 Maryland – The National Foundation for Cancer Research (NFCR) has announced three new experts in their fields will be joining the Board of Directors.…...
National Foundation for Cancer Research Announces 2021 Salisbury Award Competition Winners
FOR IMMEDIATE RELEASE: May 25, 2021 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of Commercialization and Patient Impact ROCKVILLE, MD – The National Foundation…...
Applications Open for the National Foundation for Cancer Research’s Salisbury Award Competition for Entrepreneurial Translational Cancer Research
FOR IMMEDIATE RELEASE: December 3, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Corporate Outreach E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Program is Designed to Catalyze and Advance Promising Cancer Research Innovations onto a Path of Commercialization and Patient Impact ROCKVILLE, MD – The National Foundation…...
DelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083’s Participation in a Pivotal Study for Glioblastoma Sponsored by the Global Coalition for Adaptive Research
SAN DIEGO, June 24, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today it has received a $500,000 loan from the National Brain Tumor Society (NBTS) and the National Foundation for Cancer…...
First-in-Class Drug Candidate Developed Through National Foundation for Cancer Research Funding Commences International Phase IIB Liver Cancer Clinical Trial
FOR IMMEDIATE RELEASE: May 19, 2020 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Program Development E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Three Decades of NFCR Basic and Translational Research Funding to Primary Investigator Dr. Yung-Chi Cheng and Project Advances New Systems Biology Paradigm for Cancer Treatment…...
DOWNLOAD
